Incite Health, Inc.

Breaking new ground in personalized cancer care! The latest consensus report from AMP highlights the importance of PGx testing for 5-FU chemotherapy toxicity. By identifying patients with DPYD gene variants, healthcare providers can minimize severe side effects and tailor treatments for safer, more effective cancer therapies. Discover how these new guidelines are shaping the future of precision medicine. https://lnkd.in/e_r6PTAp #Pharmacogenomics #PersonalizedMedicine #CancerCare #Chemotherapy #PrecisionMedicine #PGxTesting

Postoperative pain management is evolving with the integration of pharmacogenetics as standard of care. By tailoring analgesic protocols to an individual’s genetic profile, we can reduce opioid consumption, minimize side effects while optimizing pain management, and ultimately improve patient outcomes. Learn more here https://lnkd.in/eD4VyESS about how genotype-guided therapy is shaping the future of personalized pain management. #Pharmacogenetics #PersonalizedMedicine #PainManagement #PostoperativeCare #HealthcareInnovation

This week, our Director of National Accounts, Maryrose Nowak Roberts, had the privilege of presenting the Incite Health PGx Wellness Program to the forward-thinking team at Marsh McLennan Agency, emphasizing the significant benefits of Pharmacogenomics in shaping the future of employee wellness programs. If you’re interested in learning how our PGx wellness program can enhance your organization’s employee benefits, feel free to connect with us. #precisionmedicine #employeebenefits #healthandwellness

Pharmacogenomic testing is a game-changer in personalized medicine, uncovering genetic factors that can predict how patients respond to medications. With over 90% of the population having clinically actionable genetic variations, PGx testing is crucial for optimizing drug therapy and improving patient outcomes. Learn more about the impact of PGx on drug development and clinical practice. Read the full article here: https://lnkd.in/gyASFtfd #Pharmacogenomics #PrecisionMedicine #HealthcareInnovation #PGxTesting #BetterOutcomes

As the CEO of Incite Health, Inc., I'm proud to introduce a blog that addresses one of the most pressing issues in healthcare today: the impact of ineffective medications on patient outcomes. Written by our Chief Science Officer, Dr. Julie Bick, Ph.D., this insightful piece delves into the complexities of why some medications fail to work as intended for many patients. The implications of ineffective medications are far-reaching, affecting not only individual health but also the broader economic and societal landscapes. Dr. Bick's exploration into pharmacogenomics—a field that is rapidly transforming how we at Incite Health, Inc. approach medication management—sheds light on the precision solutions that are becoming essential in modern medicine. As you read through this blog, I encourage you to consider how these insights might inform your approach to patient care and medication management. Our commitment at Incite Health is to leverage cutting-edge science to ensure that every patient receives the most effective treatment possible. This blog is a vital part of that conversation. https://lnkd.in/eNaZv76T #healthcareInnovation #PrecisionMedicine #Pharmacogenomics #BiomarkerTesting #Leadership #LifesciencesPA #PGx #Pennsylvania

Learn how pharmacogenomic testing is transforming healthcare by optimizing drug efficacy and safety, ultimately lowering costs and improving patient outcomes. Read the latest insights from Tamara Apted and Avery Huff on the benefits of PGx in today's healthcare landscape. Article: https://lnkd.in/dwzY4taP #Pharmacogenomics #PrecisionMedicine #HealthcareEfficiency #PatientOutcomes #CostEffectiveness

Current efforts to negotiate drug prices are just the tip of the iceberg in medication management. Pharmacogenomic testing offers a targeted solution by tailoring treatments to individual genetic profiles, reducing adverse drug reactions, and improving patient outcomes. Dive into Jim Wallace's article to discover why PGx testing should become a fundamental standard of care. Read the full article here: https://lnkd.in/grCc-g-X   #Pharmacogenomics #PrecisionMedicine #HealthcareEfficiency #PatientCare #MedicationSafety #HealthEconomics

We are excited to welcome Caitlin Robertson to our laboratory operations team this summer. A junior at Syracuse University majoring in Biology and minoring in French, Caitlin has a keen interest in the conservation of endangered species and a broad range of scientific interests. Caitlin believes PGx testing should be the standard of care, reducing adverse drug reactions and eliminating the “trial and error” approach to medication selection. “Even through my own testing, I learned so much about my potential risks for drug-gene interactions.” We are proud to have Caitlin with us this summer. Learn more about Caitlin below and visit www.incitehealth.com to explore our portfolio of testing solutions. #Pharmacogenomics #PrecisionMedicine #HealthcareInnovation #PatientCare #SummerInternship

Dive into the evolving world of pharmacogenomics (PGx) and its role in Comprehensive Medication Management (CMM). This enlightening article sheds light on how genetic insights are enhancing the precision of treatments, leading to better health outcomes and cost-efficiency. Uncover the significance of PGx in shaping the future of personalized medicine.   Article: https://lnkd.in/ephvBwiw #PGx #PrecisionMedicine #HealthcareInnovation 

Introducing Danielle Perfetti, PharmD, BCMTMS! We are thrilled to welcome Danielle as Incite Health’s Pharmacist in Residence. Danielle brings her passion and expertise in Pharmacogenomics (PGx) to our team, dedicated to optimizing patient care and improving lives through personalized medicine. Her career is a testament to the power of PGx in transforming healthcare. Discover more about Danielle Perfetti below and visit Incite Health’s website to explore our comprehensive portfolio of testing solutions. #Pharmacogenomics #PrecisionMedicine #HealthcareInnovation #PatientCare